CAPITOL COUNSEL LLC for ASTRAZENECA PHARMACEUTICALS, LP
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Health care reform; drug safety and comparative effectiveness; follow-on biologics, including related provisions in comprehensive health care reform legislation: HR 3962, Affordable Health Care for America Act (House) and HR 3590, Patient Protection and Affordable Care Act (Senate).
| Lobbyist | Covered position, as disclosed |
|---|---|
| CATHERINE FINLEY | — |
| SHANNON FINLEY | — |
| SARA FRANKO | — |
| DREW GOESL | — |
| JAMES GOULD | — |
| DENISE HENRY MORRISEY | — |
| DAVID JONES | — |
| JOHN D RAFFAELLI | — |
| RICHARD LYLES SULLIVAN | — |
Medicare/Medicaid MMM
Medicare and Medicaid coverage, coding and reimbursement of pharmaceuticals and Medicare coverage gap, including related provisions in comprehensive health care reform legislation: HR 3962, Affordable Health Care for America Act (House) and HR 3590, Patient Protection and Affordable Care Act (Senate).
| Lobbyist | Covered position, as disclosed |
|---|---|
| CATHERINE FINLEY | — |
| SHANNON FINLEY | — |
| SARA FRANKO | — |
| DREW GOESL | — |
| JAMES GOULD | — |
| DENISE HENRY MORRISEY | — |
| DAVID JONES | — |
| JOHN D RAFFAELLI | — |
| RICHARD LYLES SULLIVAN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.